Merus Announces 2019 Annual General Meeting of Shareholders
UTRECHT, The Netherlands, May 23, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human bispecific antibody therapeutics, today announced that the 2019 Annual General Meeting of Shareholders will be held on June 12, 2019 at 1:00 pm (CEST) at the offices of NautaDutilh N.V. (address: Beethovenstraat 400, 1082 PR Amsterdam, the Netherlands).
All relevant documents and information for the meeting, including the notice and agenda, are available in the 'Investor Relations' section of Merus’ website (www.merus.nl) under “Financial Information”.
About Merus N.V.
Merus is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics®. Biclonics®, which are based on the full-length IgG format, are manufactured using industry standard processes and have been observed in preclinical and clinical studies to have several of the same features of conventional human monoclonal antibodies, such as long half-life and low immunogenicity. For additional information on the company and programs, please visit Merus’ website, www.merus.nl.
Investor and Media Inquiries:
Investor Relations and Corporate Communications
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Jobindex A/S29.6.2020 17:56:05 CEST | Pressemeddelelse
Stærk jobvækst i juni måned
Shandong University2.6.2020 09:01:20 CEST | Press release
Shandong University Researchers Develop ECMO Proto Device in Aid of Fighting COVID-19
Shandong University1.6.2020 12:23:16 CEST | Pressemeddelelse
Shandong University ger högteknologisk support för att bekämpa COVID-19
Shandong University1.6.2020 12:19:45 CEST | pressemelding
Shandong University låner ut høyteknologisk hjelp for å bekjempe COVID-19
Shandong University28.5.2020 13:23:12 CEST | Pressemeddelelse
Shandong University giver højteknologisk support til bekæmpelse af COVID-19
Rajant Corporation28.5.2020 06:38:26 CEST | Press release
RAJANT INTRODUCES JON LEDERMAN AS VICE PRESIDENT OF ARTIFICIAL INTELLIGENCE
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom